Articles from Coloplast A/S
The global leader within intimate healthcare today announced FDA approval of Titan Prime, an inflatable penile prosthesis (IPP) that represents the company’s next-generation device and will be available in the U.S. in late 2026.
By Coloplast A/S · Via GlobeNewswire · June 3, 2026
The contract is awarded for products that bring improvement to the healthcare industry.
By Coloplast A/S · Via GlobeNewswire · May 1, 2026
The company aims to expand its position within advanced wound care by introducing a new silicone foam that will benefit both healthcare professionals and patients.
By Coloplast A/S · Via GlobeNewswire · January 31, 2024
Coloplast’s SpeediCath® Flex Set catheter developed for people living with bladder and urinary problems is now cleared in the U.S. and will be launched in November 2022.
By Coloplast A/S · Via GlobeNewswire · November 18, 2022
Effective January 2, 2023, Tommy Johns will enter a new role as President & Senior Vice President of Coloplast’s global Interventional Urology (IU) business, replacing Steve Blum, who has decided to retire at the end of 2022.
By Coloplast A/S · Via GlobeNewswire · November 15, 2022
Coloplast is introducing the Saffron™ Fixation System designed for ease and reliability during pelvic floor reconstruction for women who suffer from pelvic organ prolapse (POP).
By Coloplast A/S · Via GlobeNewswire · October 6, 2022